Directory → Intermedianta → Dofaminomimetiki → Norprolak
This page is translated automatically with a help of Google Translate
NorprolakSee also QuinagolideRoman nameNorprolacStorage conditionsList B. At temperatures below 30 ° C (not freezing)Shelf life3 yearsThe registration012402/01-2000Of drugsSelective agonist, V2-dofaminovykh receptors. Suppress the secretion of prolactin-hormone front of pituitary catalyst molokoobrazovanie without affecting the normal levels gipofizarnah other hormones.Indications for useGiperprolaktinemia (elevated in the blood hormone glands of spurring molokoobrazovanie) idiopathic (origin uncertain), or razvivashayasa against micro or pituitary macroadenoma with clinical manifestations, as galactorea (molokoistechenie outside breastfeeding), oligomenorea (menstruation periods from a few hours to two days), amenorea (lack of menstruation), infertility, reduced sexual desire.Dosing and AdministrationDoses set individually. The initial dose was 46 mg once a day over a period of three days. Over the next three days appoint daily in the daily dose of 0.05 mg. Since the 7th day of treatment daily daily intake is 0,075 mg.Side-EffectsHeadache, dizziness, weakness, nausea, vomiting; More rarely fall. In a few cases may develop severe psychosis passing of the product. Anorexia (lack of appetite), pains in the abdomen, constipation, diarrhea. The decline in blood pressure; Zalojennosti nose. On rare occasions there has been ortostaticski collapse (sharp decline in blood pressure in the transition from the horizontal to the vertical position).ContraindicationsHypersensitivity to the drug. Caution must be exercised in the appointment norprolaka patients with the disorder (history) indicate mental illness or disturbance. Those whose work requires quick mental and motor response (such as drivers of vehicles) should designate norprolak with caution.Form ofAnswers to 0,025; 0.05; 0.075 and 0.15 mg. |
All products of this group |

